ALIDA GRIFFITH: Open Payments
NPI 1861474793 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 21 payments from 13 companies in 2025. Trend: 2023 $534 · 2024 $583 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $120 |
| Merz Pharmaceuticals, LLC | 3 | $81 |
| ABBVIE INC. | 2 | $57 |
| Boston Scientific Corporation | 2 | $45 |
| Abbott Laboratories | 1 | $43 |
| CSL Behring | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| TG Therapeutics, Inc. | 1 | $22 |
| ARGENX US, INC. | 1 | $19 |
Products named: Xeomin, Vercise, INFINITY, Hizentra, AMVUTTRA, VYALEV, BOTOX, KESIMPTA.
Industry payments across WA — which companies pay providers there.
